Boardroom Alpha
Boardroom Alpha
VRA · Current Report (Form 8-K) · Filed June 9, 2026

Vera Bradley Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 9, 2026
Period
Jun 4, 2026
Ticker
VRA
Accession
0001628280-26-041779
Boardroom Alpha · Filing insights

Shareholders elected six directors, ratified Deloitte as auditor, approved executive compensation, and authorized 3,000,000 additional shares.

About Vera Bradley Inc
Market cap
$91M
1Y TSR
+68.5%
3Y TSR
−21.2%
Board grade
B
Sector
Consumer Cyclical
CEO
Ian Bickley
Last annual meeting: Jun 4, 2026 · View full Vera Bradley Inc profile →
vra-20260604


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM 8-K
___________________________
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 4, 2026
___________________________ 
VERA BRADLEY, INC.
(Exact name of registrant as specified in its charter)
___________________________
 
Indiana 001-34918 27-2935063
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
12420 Stonebridge Road,
Roanoke, Indiana
 46783
(Address of Principal Executive Offices) (Zip Code)
(877) 708-8372
(Registrant’s telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
___________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of each exchange on which registered
Common Stock, without par valueVRANASDAQ Global Select Market



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o




Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company’s 2026 Annual Meeting of Shareholders was held on June 4, 2026. At the meeting, the Company’s shareholders:
(1)elected Ian Bickley, Ivan Brockman, Kristina Cashman, Robert J. Hall, Andrew Meslow, and Jessica Rodriguez to serve as Directors of the Company’s Board of Directors for a one-year term;
(2)ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027;
(3)approved, on an advisory basis, the compensation of the Company’s named executive officers; and
(4)approved an amendment to the 2020 Equity and Incentive Plan to add an additional 3,000,000 shares of common stock to the plan.
    
Set forth below, with respect to each such matter, are the number of votes cast for or against, the number of abstentions, and the number of broker non-votes.
(1)Election of Directors
NomineeForWithholdBroker Non-Votes
Ian Bickley17,304,50916,0855,235,449
Ivan Brockman17,301,95618,6385,235,449
Kristina Cashman16,413,577907,0175,235,449
Robert J. Hall12,405,4674,915,1275,235,449
Andrew Meslow17,301,36319,2315,235,449
Jessica Rodriguez17,189,289131,3055,235,449
(2)Ratification of Appointment of Independent Registered Public Accounting Firm
ForAgainstAbstentionsBroker Non-Votes
21,251,9711,296,0787,994
(3)Advisory Approval of the Company's Named Executive Officer Compensation
ForAgainstAbstentionsBroker Non-Votes
13,401,7213,889,59029,2835,235,449
(4)Approval to add an additional 3,000,000 shares of common stock to the 2020 Equity and Incentive Plan
ForAgainstAbstentionsBroker Non-Votes
11,501,8535,157,094661,6475,235,449
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
104Cover Page Interactive Data File (embedded within the Inline XBRL document)






SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Vera Bradley, Inc.
(Registrant)
Date: June 9, 2026
/s/ Daniel Ross
Daniel Ross
General Counsel

 




From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Vera Bradley Inc (VRA)

Reference

Frequently asked questions

When did Vera Bradley Inc file this 8-K?
Vera Bradley Inc (VRA) filed this Current Report (Form 8-K) with the SEC on June 9, 2026. The accession number assigned by EDGAR is 0001628280-26-041779.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders elected six directors, ratified Deloitte as auditor, approved executive compensation, and authorized 3,000,000 additional shares. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Vera Bradley Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Vera Bradley Inc has filed under CIK 1495320, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer